Description

Collaborations are key in achieving scientific progress. The European Horizon COST Actions provide great opportunities to build, grant, and/or participate in pan-European collaborations in multidisciplinary topics, including liver diseases.

This EASL Studio:

• Provides you with information about the COST Action programme.
• Discusses the structure of the drug-induced liver injury (DILI) and cholangiocarcinoma (CCA) working groups.
• Highlights the potential for collaborative work within this programme.

Faculty

• Prof. Jesús Bañales (Moderator)
• Prof. Raul Andrade (Faculty)
• Dr Chiara Braconi (Faculty)
• Prof. Vincenzo Cardinale (Faculty)

Related episodes

• S4E13: EASL-EF CLIF and EU Grants: Exploring novel mechanisms and treatment of chronic liver failure
• S4E2: YI Choice: How to build consortia and registries

Listen to the podcast